Big pharma’s patent cliff meets a new biotech Cold War: We need to outrun China, not outlaw it
Patrick Swayze, Alex Trebek, and Ruth Bader Ginsburg all died of pancreatic cancer. They were wealthy enough to afford any treatment that existed. But there simply wasn’t a drug available — at any price — that could save their lives.
- ▪Patrick Swayze, Alex Trebek, and Ruth Bader Ginsburg all died of pancreatic cancer.
- ▪They were wealthy enough to afford any treatment that existed.
- ▪But there simply wasn’t a drug available — at any price — that could save their lives.
Fortune files mainly under business. We currently carry 644 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Fortune |
| Canonical URL | https://fortune.com/2026/07/24/big-pharma-patent-cliff-cold-war-china-biotech/ |
| Publication time | Fri, 24 Jul 2026 11:30:00 +0000 |
| Retrieval time | 2026-07-24T11:42:39.105Z |
| Last seen | 2026-07-24T11:42:39.105Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | wkQOA338Oe94 |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Patrick Swayze, Alex Trebek, and Ruth Bader Ginsburg all died of pancreatic cancer. They were wealthy enough to afford any treatment that existed. But there simply wasn’t a drug available — at any price — that could save their lives. This is the cruelest access problem in healthcare. The most expensive illness is not the one with the costliest drug, but the one with no drug at all. The price of a cure not yet invented is effectively infinite.Recommended Video That was true for pancreatic cancer, until now. This spring, Revolution Medicines reported that its experimental treatment daraxonrasib nearly doubled survival in pancreatic cancer patients who were out of other options. The new drug seems almost miraculous. A year ago, former Senator Ben Sasse was told he had a month to live.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Fortune.
Discussion
0 commentsMore from Fortune
